First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin
Clinical trial NCT00981058 · COMPLETED
Trial details
- NCT number
- NCT00981058
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-07
- Primary completion
- 2013-06-17
- Enrollment
- 1093
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.